Indo-Bangla Pharmaceuticals (DHA:IBP) OCF Margin %: 0.00% (As of . 20)


DHA:IBP Indo-Bangla Pharmaceuticals Ltd DHA:IBP
32 GF Score
Price BDT15.30
View Full Analysis

What is Indo-Bangla Pharmaceuticals OCF Margin %?

Indo-Bangla Pharmaceuticals DHA:IBP +1.32% 32 OCF Margin % is 0.00% as of . 20. GuruFocus rates DHA:IBP with a GF Score™ of 32/100. Among 959 Drug Manufacturers companies, Indo-Bangla Pharmaceuticals ranks worse than 104275.18% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Indo-Bangla Pharmaceuticals's Cash Flow from Operations for the six months ended in . 20 was BDT0.00 Mil. Indo-Bangla Pharmaceuticals's Revenue for the six months ended in . 20 was BDT0.00 Mil. Therefore, Indo-Bangla Pharmaceuticals's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Indo-Bangla Pharmaceuticals's current OCF Yield % is 0.00%.

The historical rank and industry rank for Indo-Bangla Pharmaceuticals's OCF Margin % or its related term are showing as below:


DHA:IBP's OCF Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.94
* Ranked among companies with meaningful OCF Margin % only.

Indo-Bangla Pharmaceuticals OCF Margin % Related Terms

Indo-Bangla Pharmaceuticals OCF Margin % Historical Data

* Premium members only.

The historical data trend for Indo-Bangla Pharmaceuticals's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indo-Bangla Pharmaceuticals OCF Margin % Chart

Indo-Bangla Pharmaceuticals Annual Data
Trend
OCF Margin %

Indo-Bangla Pharmaceuticals Semi-Annual Data
OCF Margin %
DHA:IBP
32GF Score
Indo-Bangla Pharmaceuticals Ltd DHA:IBP
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Indo-Bangla Pharmaceuticals OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Indo-Bangla Pharmaceuticals's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

Indo-Bangla Pharmaceuticals's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indo-Bangla Pharmaceuticals and its competitors. According to the industry distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 959 companies in the Drug Manufacturers industry.
Is Indo-Bangla Pharmaceuticals' OCF Margin % too high?
Indo-Bangla Pharmaceuticals' current OCF Margin % is 0.00%. Based on the distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 959 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Indo-Bangla Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Indo-Bangla Pharmaceuticals' OCF Margin % compare to ?
According to the Drug Manufacturers industry distribution chart, Indo-Bangla Pharmaceuticals ranks #999999 out of 959 companies for OCF Margin %. This places Indo-Bangla Pharmaceuticals in the lower half of its industry. The industry median OCF Margin % is 9.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Indo-Bangla Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo-Bangla Pharmaceuticals's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo-Bangla Pharmaceuticals stock overvalued right now?
Indo-Bangla Pharmaceuticals (DHA:IBP) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Indo-Bangla Pharmaceuticals' overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Indo-Bangla Pharmaceuticals (DHA:IBP), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Indo-Bangla Pharmaceuticals Business Description

Comparable Companies
Address Ahmed Akbar Sobhan Road, Block B, Plot No. 183, 6th Floor, Bashundhara R/A, Baridhara, Dhaka, BGD, 1229
Indo-Bangla Pharmaceuticals Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products. The products of the company include human drugs dosages form such as tablets, capsules, syrup, oral saline, and suspension. The products of the company are sold in the domestic market.
32GF Score

Get the complete analysis for DHA:IBP

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT15.30
Price